Searched for
ALLEGRA D 12
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhen markets come under the kind of pressure they are experiencing these days, the bears don't see fundamentals; it is all about selling. A...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe Indian markets on Wednesday rose in lockstep with global peers that reacted, among other things, to the possibility of an end to the Ru...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe way things are panning out in the markets, the bulls are steadily but clearly gaining control. Yes, we will continue to see small phase...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsCan we at this point say that valuations are fairly priced in the mid-cap segment? The answer is no. Does it mean that you should avoid the...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is now quite clear that the underlying bias of the market has changed. Both the indices and market breadth are positive. And the festive...
- These mid-cap stocks with ‘strong buy’ & ‘buy’ recos can rally over 26%, according to analystsThere are earnings seasons and their earnings seasons. While every earnings season is important, some are more important than others as the...
- What makes them different is RoE: 15 large-cap stocks from different sectors with upside potential of 24 to 51% in 1 yearReturn on Equity (RoE) is a crucial financial ratio that helps investors evaluate a company's profitability and efficiency in generating re...
- When net profits grow faster than economy: 6 stocks with up to 41% upside potentialStocks that consistently beat the economy when it comes to growth, have the ability to generate above-average returns in the medium to long...
- Dr Reddy's launches generic version of Allegra D in US"We are pleased to be expanding our pseudoephedrine-based product offering in time for the cough, cold and allergy season," Dr Reddy's Seni...
- Afraid of bears on D-Street? You may just need Vitamin D3The global market for Vitamin D may hit $2.5 billion by 2020 growing at a CAGR of 11 per cent.
- Dr Reddy's announces launch of OTC tablets in US marketDr Reddy's Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg is available in a 20 count ...
- Dr Reddy's launches Fexofenadine HCl in USDr Reddy's Laboratories today announced the launch of generic version of Allegra -- Fexofenadine HCl -- tablets in the US market.
- Wockhardt gets USFDA tentative nod for generic rhinitis drugPharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...
- Dr Reddy's looks at settling Sanofi dispute out of courtPharma major Dr Reddy’s Laboratories (DRL) is contemplating an out-of-court settlement with the French company Sanofi-Aventis for anti-alle...
Load More
